{"filings":[{"id":2578757,"accession_number":"0001628280-26-059619","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-08-31T20:55:32+00:00","items":["5.07","9.01"],"status":"ready","headline":"Ascend Wellness shareholders approve reverse stock split (1-for-10 to 1-for-50)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting Aug 28, 2026: 112,305,378 votes for reverse split, 1,391,090 against, 6,371 withheld.","Board may set ratio from 1-for-10 to 1-for-50 before national exchange listing or 1 year from meeting, whichever first.","Adjournment proposal also passed (113,245,527 for) but not needed since split received sufficient votes.","Total 113,702,839 Class A shares represented, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2216916,"accession_number":"0001628280-26-056190","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-08-12T20:10:21+00:00","items":["2.02","9.01"],"status":"ready","headline":"AWH Q2 2026 revenue $126.1M (+7.9% seq), Adj EBITDA $29.1M; reverse split vote Aug 28","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2026 net revenue $126.1M, up 7.9% sequentially from $116.9M; retail revenue $92.7M (+11.5%).","Adjusted EBITDA $29.1M (23.1% margin), up from $26.3M in Q1; net loss narrowed to $9.8M from $29.5M.","Cash $67.0M, up $6.1M sequentially; operating cash flow $22.5M, FCF $19.5M; net debt $251.8M.","Retail footprint 55 locations (vs 48 at Q1 end); year-end target 60; reverse stock split shareholder vote Aug 28, 2026 for uplisting.","Q3 2026 outlook: revenue +2-4% sequentially, EBITDA margin consistent with Q2; Barry, IL work stoppage resolved Aug 3, potential Q3 impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1278158,"accession_number":"0001104659-26-077802","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-06-25T20:43:50+00:00","items":["5.03","9.01"],"status":"ready","headline":"Ascend Wellness reduces stockholder meeting quorum to one-third of voting power","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board amended bylaws to lower quorum from majority to one-third of outstanding voting power.","Effective June 24, 2026; applies unless required otherwise by law or charter.","No other material changes were made to the bylaws."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":68601,"accession_number":"0001628280-26-034616","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-05-13T20:18:30+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q1 net revenue $116.9M, net loss $29.5M, Adj EBITDA $26.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue of $116.9M, down 3% sequentially from Q4 2025; retail $83.1M, wholesale $33.8M.","Net loss narrowed to $29.5M from $48.7M in Q4 2025; Adj EBITDA $26.3M (22.5% margin).","Added 5 dispensaries YTD; total 51 locations; targeting at least 60 by year end.","Michigan facility to temporarily suspend operations in late Q2 2026 for fire remediation.","Q2 2026 guidance: revenue expected +2-3% sequentially; Adj EBITDA margin low-20% range."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95219,"accession_number":"0001628280-26-030618","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["3.03","5.03","5.07","9.01"],"status":"ready","headline":"Ascend Wellness Holdings completes Class B conversion and annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On May 4, 2026, all 65,000 outstanding Class B shares of Ascend Wellness automatically converted into Class A shares.","The company retired the converted Class B shares, reducing authorized common stock to 750,035,000 and Class B authorized to 35,000.","At the April 29, 2026 annual meeting, all six director nominees were elected, each receiving over 95 million votes for.","Stockholders ratified WithumSmith+Brown as auditor with 170,618,274 votes for and reapproved the stock incentive plan with 98,316,897 votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108120,"accession_number":"0001628280-26-017248","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness reports Q4 2025 revenue $120.5M; net loss widens to $48.7M; FY revenue $500.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $120.5M (down 3.4% sequentially); FY2025 revenue $500.6M (down 10.9% YoY).","Q4 net loss $48.7M (includes $17M arbitration settlement); FY net loss $118.2M vs $85.0M loss in FY2024.","Adjusted EBITDA Q4 $30.2M (margin 25.1%); FY $116.9M (margin 23.4%) vs $116.2M prior year.","Cash $85.7M; net debt $215.8M; $26M capex in FY2025; retail footprint expanded to 48 locations.","Q1 2026 guidance: low- to mid-single-digit revenue decline; adjusted EBITDA margin low-20% range."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108119,"accession_number":"0001628280-26-008154","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness settles arbitration with GTI for $17M, down from $19.7M award","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement payment of $17M made to GTI, resolving $19.7M arbitration award from Feb 6.","Agreement dated Feb 11, 2026; all claims in arbitration fully satisfied and discharged.","Company states no material disruption to ongoing operations expected.","Resolves dispute under June 2018 side letter agreement between the parties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108118,"accession_number":"0001628280-26-006199","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-02-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness prelim Q4 rev ~$120M, FY rev ~$500M; GTI arbitration award","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 net revenue ~$120M, Adjusted EBITDA ~$30M (25% margin); FY 2025 net revenue ~$500M, Adj EBITDA ~$117M (23% margin).","Cash and equivalents ~$86M; no significant debt maturities until 2029; liquidity sufficient for operations.","Retail footprint expanded to 47 stores; record SKUs and market share gains cited by CEO.","Arbitration award from Green Thumb Industries issued Feb 5, 2026; company disagrees, evaluating options, says has ample liquidity to satisfy if required."],"consensus_eps_estimate":-0.1162,"consensus_eps_actual":-0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":500581000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108117,"accession_number":"0001628280-26-006090","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness loses arbitration to Green Thumb; net award $19.7M","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Arbitrator found both Ascend and Green Thumb breached purchase-obligation agreement from June 2018.","GTI awarded ~$22M; Ascend awarded ~$2.3M; net award to GTI ~$19.7M.","Company disagrees with decision and is evaluating options.","Company does not currently expect material disruption to operations from award.","Dispute centered on side letter from Ascend's capital raise in 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124530,"accession_number":"0001628280-25-051045","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q3 2025: net loss $25.8M, adj EBITDA $31.1M (24.9% margin), revenue $124.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $124.7M, down 2% sequentially; retail $83.8M (-3.1%), wholesale $41.0M (+0.3%).","Adjusted EBITDA $31.1M, up 8.9% QoQ; adjusted gross margin 46.4% (+300bps seq).","Net loss $25.8M vs $24.4M in Q2; cash $87.3M, net debt $281.8M.","Opened 2 stores in Q3; pipeline of 13 stores; target 60 locations in 12 months.","Closed $9.3M Ohio mortgage loan at 8.5% due 2030; repurchased 1M shares in Q3."],"consensus_eps_estimate":-0.0909,"consensus_eps_actual":-0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":380035000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141214,"accession_number":"0001628280-25-038887","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q2 revenue $127.3M flat; net loss widens to $24.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $127.3M, flat QoQ (down 0.5%); retail revenue up 2.5% to $86.5M, wholesale down 6.4%.","Net loss $24.4M vs $19.3M in Q1; higher G&A partially offset by margin improvements.","Adjusted EBITDA $28.6M (22.4% margin), up 5.7% QoQ and margin up 130 bps.","Fully retired $60M term loan via $50M private placement of 12.75% Senior Secured Notes due 2029 and $10M cash.","Ended Q2 with $95.3M cash; generated $17.8M operating cash flow (10th straight positive quarter)."],"consensus_eps_estimate":-0.0758,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":255301000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159017,"accession_number":"0001628280-25-028199","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["2.03","8.01"],"status":"ready","headline":"Ascend Wellness issues $50M 12.75% senior secured notes due 2029 to repay credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $50M aggregate principal of 12.75% senior secured notes due 2029 at 97.5% of face value.","Proceeds, with cash on hand, to prepay remaining $60M under 2021 Credit Facility plus accrued interest.","Additional notes are treated as a single series with existing $250M initial notes under same indenture.","Interest payable semi-annually on Jan 15 and Jul 15; first payment Jul 15, 2025 includes accrued interest.","Notes mature July 16, 2029; initially separate CUSIP, fungible after four months and one day."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159016,"accession_number":"0001628280-25-024683","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q1 2025 net revenue $128M, Adj EBITDA $27M, cash from ops positive $5.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue of $128.0M; Adjusted EBITDA of $27.0M (non-GAAP); Adjusted Gross Margin 40.8%.","Generated $5.9M cash from operations, ninth consecutive quarter of positive operating cash flow.","Ended Q1 2025 with $100.0M cash; targeting ten new stores in 2025 (Ohio, PA, IL, NJ).","Cost savings transformation initiatives continued; improving balance sheet and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":127997000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159015,"accession_number":"0001628280-25-021905","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Ascend Wellness stockholders elect all six director nominees and ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six board nominees (Kurtin, Perullo, Swid, Gold, Brill, Francis) elected; each received over 95 million votes for.","Stockholders ratified WithumSmith+Brown, PC as independent auditor for FY2025; 168.2 million votes for, 58,719 against.","Broker non-votes on director election totaled 64.7 million shares; no broker non-votes on auditor ratification.","Annual meeting held April 30, 2025; quorum of 168.3 million shares represented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177459,"accession_number":"0001628280-25-014312","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Ascend Wellness Holdings dismisses MGO and appoints Withum as new auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["MGO dismissed as independent auditor effective March 19, 2025; no adverse opinions or modifications in its reports for 2023 and 2024.","No disagreements or reportable events occurred during the two fiscal years ended 2024 and subsequent interim periods.","Audit committee and board approved dismissal; MGO's SEC letter agreeing with statements is filed as Exhibit 16.1.","WithumSmith+Brown appointed as new independent registered public accounting firm for fiscal year 2025, effective March 19, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177458,"accession_number":"0001628280-25-012342","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q4 2024 Adj. EBITDA $30.2M; FY revenue $562M (+8% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 net revenue $562M (+8% YoY); Adj. EBITDA $116M (+9% YoY).","Q4 2024 Adj. EBITDA $30.2M; Adj. Gross Margin 41.9% (ahead of expectations).","Generated $30.1M Free Cash Flow in Q4; ended quarter with $88M cash.","Ten stores in development (OH, PA, IL, NJ) as part of densification strategy.","Launched Effin' brand; achieved top edible spot in Ascend stores."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177457,"accession_number":"0001628280-25-001438","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ascend Wellness issues $15M additional 12.75% senior secured notes due 2029 at 97% of face","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $15M of 12.75% senior secured notes due 2029 at 97% face value, plus accrued interest from July 16, 2024.","Additional notes are fungible with existing $235M initial notes after four months and one day.","Net proceeds for general corporate purposes, including growth initiatives.","First supplemental indenture permits social equity / female- or minority-owned investments and changes liquidity covenant to monthly testing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194190,"accession_number":"0001628280-24-052527","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-12-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness authorizes share buyback of up to 5% of shares or $2.25M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved NCIB effective Jan 2, 2025 to repurchase up to 10,215,690 shares (~5% of outstanding) or $2.25M, whichever is less.","Purchases will be made on CSE, OTCQX, or alternative systems via ATB Securities Inc.; all shares bought will be cancelled.","Program expires Jan 1, 2026, but may be suspended, terminated, or modified at any time; no obligation to buy any shares.","As of Dec 24, 2024, there were 204,313,808 common shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194189,"accession_number":"0001628280-24-051714","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness repurchases 11M shares (over 5% outstanding) at discount from institutional investor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Repurchased 11,000,000 Class A common shares from an institutional investor in a private transaction, representing over 5% of outstanding shares.","The shares were bought at a significant discount to the December 17, 2024 closing price on the CSE and were cancelled.","Board unanimously approved the repurchase; consent from term loan holders allows up to $5M in share repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194188,"accession_number":"0001628280-24-046851","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q3 net revenue $141.6M flat YoY; net loss widens to $28.3M, Adj EBITDA down 14.9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $141.6M (+0.3% YoY); retail $93.6M (-7.6% YoY), wholesale $48.0M (+20.1% YoY).","Net loss $28.3M vs $11.2M loss in Q3 2023; adjusted EBITDA $25.1M (17.7% margin), down 14.9% YoY and 11.4% QoQ.","Announced $30M annual cost savings initiatives; reduced management headcount by 15% at corporate, 10% at retail/ops.","Cash $65.3M; net debt $240.6M; generated $2M operating cash flow, 7th consecutive positive quarter.","Began adult-use sales at 5 Ohio dispensaries; opened 1 new PA store; total 39 operating dispensaries."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":425593000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210516,"accession_number":"0001628280-24-038714","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-08-28T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ascend Wellness replaces CEO and CFO; appoints Samuel Brill as CEO, Roman Nemchenko as CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Hartmann removed as CEO effective Aug 26, 2024; Samuel Brill (formerly Lead Independent Director) appointed CEO.","Mark Cassebaum terminated as CFO; Roman Nemchenko (formerly CAO) appointed CFO effective immediately.","Frank Perullo appointed President; co-founder with prior roles including interim Co-CEO and EVP Corporate Affairs.","Brill receives $550k base salary, 5M RSUs; Nemchenko receives $450k base, $175k guaranteed FY2024 bonus, 350k RSUs.","Company cites need to address 'recent performance challenges' and realign strategy with new leadership team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210515,"accession_number":"0001628280-24-034523","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q2 net revenue $141.5M (+15% YoY); net loss of $21.8M vs prior year net income","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $141.5M, up 15.1% YoY; gross wholesale revenue +30.1% YoY to $79.6M.","Adjusted EBITDA $28.3M (20.0% margin), up 32.9% YoY; net loss $21.8M vs net income $0.8M in Q2 2023.","Retail revenue $93.1M (+3.6% YoY); wholesale net revenue $48.5M (+46.2% YoY).","Cash and cash equivalents $83.7M; net debt $225.6M as of June 30, 2024.","Generated ~$32M cash from operations (sixth consecutive positive quarter), incl. ~$18M tax refunds."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":283946000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210514,"accession_number":"0001628280-24-032485","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Ascend Wellness closes $235M 12.75% notes due 2029, refinances term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $235M senior secured notes at 94.75% of face value, maturing July 16, 2029.","Net proceeds plus cash on hand used to prepay $215M of existing term loan.","Remaining $60M term loan at 9.5% rate can be repaid at par after Feb 27, 2025.","Notes bear 12.75% interest, semi-annual payments; first two years redeemable at par.","Seaport Global Securities acted as sole placement agent for the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210513,"accession_number":"0001628280-24-031837","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ascend Wellness issues $235M 12.75% senior secured notes due 2029 to refinance term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Private placement of $235M 12.75% Senior Secured Notes due 2029, issued at 94.75% of face value.","Net proceeds of ~$213.3M, plus cash, to prepay $215M of existing term loan maturing in 13 months.","Notes mature July 2029; early redemption allowed at par for first two years.","Remaining $60M of term loan may be carried at 9.5% interest to original maturity.","Fifth consecutive quarter of positive cash from operations; CEO cites enhanced financial flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228841,"accession_number":"0001628280-24-025933","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-05-31T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ascend Wellness appoints Julie Francis to board; expands to 7 directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Julie Francis appointed to Board effective June 3, 2024; board expands from 6 to 7.","Board determined Ms. Francis qualifies as independent director under SEC and NYSE standards.","Ms. Francis will serve on the Compensation and Governance Committee.","Ms. Francis is COO of Schwan's Company; prior roles at Constellation Brands and Coca-Cola.","Compensation consistent with non-employee directors as disclosed in April 2024 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228840,"accession_number":"0001628280-24-020840","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","5.07","9.01"],"status":"ready","headline":"Ascend Wellness Q1 net revenue $142.4M (+25% YoY); Adj. EBITDA $32.5M (+39% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Gross revenue $174.2M (+23.4% YoY); net loss $18.2M vs $18.5M a year ago.","Wholesale net revenue $47.2M (+50.2% YoY); retail revenue $95.2M (+15.1% YoY).","Generated $3.9M operating cash flow, fifth consecutive positive quarter.","Cash $72.9M, net debt $237.6M as of March 31, 2024.","Annual meeting elected six directors and ratified Macias Gini & O'Connell LLP as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":142410000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228839,"accession_number":"0001756390-24-000001","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ascend Wellness transitions Chairman Kurtin and EVP Perullo; separation payments total $5.78M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Abner Kurtin retains Executive Chairman role with $200k salary; $150k RSU; no bonus or severance.","Kurtin receives $3.3M termination payment and accelerated vesting of ~1.8M equity awards.","Francis Perullo moves to EVP Corporate Affairs with $450k salary, up to 100% bonus, LTIP from FY2025.","Perullo gets $2.475M separation payment and accelerated vesting of ~1.28M options/RSUs.","Both agreements are at-will; Perullo's includes severance; Kurtin's is one-year term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247486,"accession_number":"0001628280-24-010368","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Q4 net revenue $140M (+25% YoY), adjusted EBITDA $32M; first full year positive ops cash flow","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 net revenue $140.2M, up 25.0% YoY; full year net revenue $518.6M, up 27.8% YoY.","Net loss narrowed to $48.2M in FY 2023 from $80.9M in FY 2022; Q4 net loss $19.3M.","Adjusted EBITDA Q4 $32.4M (+14.8% YoY); full year $106.5M (+14.3% YoY).","First full year of positive cash from operations ($54.5M) and positive free cash flow ($30.3M, excl. $20.8M ERTC).","Ended Q4 with $72.5M cash; net debt $236.2M; opened 6 dispensaries in 2023, total now 35."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264944,"accession_number":"0001628280-23-037178","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q3 net revenue $141.3M (+27% YoY); Adj. EBITDA $29.5M up 38.5% QoQ","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue of $141.3M, up 27.0% YoY and 14.9% QoQ; record 6th consecutive quarterly high.","Adjusted EBITDA of $29.5M (20.9% margin), improved 356 bps sequentially; net loss narrowed to $11.2M from $16.9M.","Retail revenue $101.3M (+22.3% YoY); wholesale net revenue $40.0M (+40.6% YoY).","Generated positive cash from operations for third straight quarter and first quarter of positive free cash flow.","Cash and equivalents $63.9M; net debt $243.5M as of Sept 30, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":378432000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264943,"accession_number":"0001628280-23-035038","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Ascend Wellness reports record Q3 revenue ~$140M, up 15% Q/Q; names Mark Cassebaum CFO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary Q3 net revenue ~$140M (record, +15% Q/Q).","Adjusted EBITDA estimated at $27-29M, significant sequential growth.","Third straight quarter positive cash from operations; first quarter positive free cash flow.","Mark Cassebaum appointed CFO effective Nov 27, 2023; Dan Neville resigning Nov 10.","CFO compensation: $450K base, bonus up to 100%, one-time $135K cash, 350K RSUs vesting over 4 years."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":378432000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282131,"accession_number":"0001628280-23-028251","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q2 net revenue $123M (+26% YoY), net income $0.8M vs loss year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue of $123.0M, up 26.1% YoY and 7.7% QoQ; gross revenue $151.0M, up 28.4% YoY.","Net income of $0.8M vs net loss of $21.2M in Q2 2022; positive GAAP profitability.","Adjusted EBITDA $21.3M (17.3% margin); cash flows from operations $25.4M, second consecutive positive quarter.","Retail revenue $89.9M (+18.9% YoY); wholesale revenue net of intercompany $33.1M (+51% YoY).","Cash and equivalents $68.0M; net debt $241.8M as of June 30, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":237164000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301241,"accession_number":"0001628280-23-022364","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-06-16T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Ascend Wellness raises $7M via private placement of 9.86M shares at $0.71/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 9,859,155 shares at $0.71 per share to a single accredited investor for $7M gross proceeds.","Net proceeds will be used to pursue acquisitions of debt or equity in cannabis companies.","Shares issued under Rule 506(b) exemption; no underwriting discounts paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301240,"accession_number":"0001628280-23-022131","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-06-15T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness acquires ~$12M of secured debt of a cannabis operator","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Acquired ~2/3 of outstanding secured indebtedness of a cannabis grow, processing, and dispensary operator.","Cash consideration of approximately $12 million in a private transaction.","Transaction closed June 14, 2023.","No counterparty name or strategic rationale disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301239,"accession_number":"0001628280-23-016903","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","5.02","5.07","9.01"],"status":"ready","headline":"Q1 revenue up 34% to $114.2M; appoints John Hartmann as CEO effective May 15","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $114.2M (+34.2% YoY); net loss improved to $18.5M from $27.8M.","Adjusted EBITDA $23.3M (20.4% margin), up 42% YoY; cash $73.3M, net debt $250.8M.","John Hartmann appointed CEO effective May 15; base salary $950k, 6M RSU grant.","Frank Perullo transitions to Strategic Advisor; Dan Neville returns to CFO, resigns board.","Stockholders approved amendment to stock plan increasing shares to 10% of outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":114176000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301238,"accession_number":"0001628280-23-014877","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Ascend Wellness closes acquisition of Devi Holdings for $12M cash and 5.185M shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed acquisition of 100% of Devi Holdings membership interests; total consideration includes $12M cash (subject to adjustments) and 5,185,186 Class A shares.","Shares issued under Section 4(a)(2) exemption as private placement to limited holders without general solicitation.","Acquisition originally announced Jan 24, 2023; closing occurred April 27, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321094,"accession_number":"0001628280-23-007855","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2023-03-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q4 net revenue $112.1M (+26.7% YoY); Adjusted EBITDA $28.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 net revenue $112.1M, up 26.7% YoY; full year net revenue $405.9M, up 22.1% YoY.","Q4 2022 net loss $15.1M vs $16.9M in Q3 2022; full year net loss $80.9M vs $122.7M in FY 2021.","Q4 2022 Adjusted EBITDA $28.2M (margin 25.1%), up 42.7% year-over-year.","Cash and equivalents $74.1M at Dec 31, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339201,"accession_number":"0001628280-22-030744","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-11-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ascend Wellness appoints Joshua Gold and Daniel Neville to board; Paxhia resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joshua Gold appointed as independent director, chair of Audit Committee and member of Compensation and Corporate Governance Committee.","Daniel Neville, current Interim Co-CEO and CFO, appointed as director; will not serve on any committees.","Gold receives 125,000 RSUs (50% vest at 1 yr, 50% at 2 yr) and a warrant for 188,000 shares at $2.64, 30-month term.","Emily Paxhia resigned effective Nov 23, 2022; no disagreement with company operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339200,"accession_number":"0001628280-22-029504","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q3 net revenue $111.2M (+14% QoQ); adjusted EBITDA $27.8M, 25% margin, +354bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $111.2M, up 14.1% QoQ and 17.9% YoY; gross revenue $134.3M.","Net loss narrowed to $16.9M from $21.2M in Q2 2022.","Adjusted EBITDA $27.8M (25.0% margin), expanding 354 bps sequentially.","Cash and equivalents $91.4M; net debt $219.0M as of Sept 30, 2022.","Started adult-use sales at Montclair, NJ; opened Fort Lee dispensary and Franklin kitchen for edibles."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":293827000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339199,"accession_number":"0001628280-22-025974","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-10-04T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Compensation Committee investigation into Executive Chairman completes; no action","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee investigation into allegations against Executive Chairman Abner Kurtin completed; no action warranted.","Criminal charges against Kurtin dismissed on September 30, 2022.","Committee determined no violation of Company's Code of Business Conduct and Ethics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356578,"accession_number":"0001628280-22-025593","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-09-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ascend Wellness appoints Interim Co-CEOs Perullo and Neville; Kurtin becomes Executive Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Frank Perullo (President) and Daniel Neville (CFO) appointed Interim Co-CEOs effective Sept 27, 2022.","Founder/former CEO Abner Kurtin transitions to Executive Chairman with non-material contract amendments.","Perullo and Neville retain existing roles; no compensation changes for the Co-CEO appointments.","Board has commenced search for a permanent CEO.","Perullo co-founded company, Neville joined in 2019 and became CFO in 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356577,"accession_number":"0001628280-22-024946","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-09-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Joseph Hinrichs resigns from Ascend Wellness board effective Sept 14, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph Hinrichs resigned from the Board, Audit Committee, and Compensation and Corporate Governance Committee, effective immediately.","Resignation due to his appointment as CEO of another company; not related to any disagreement with the Company or management.","Board has commenced a search for a new director to fill the vacancy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356576,"accession_number":"0001628280-22-022983","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-08-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness terminates proposed MedMen NY acquisition over asset condition concerns","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["On August 15, 2022, Ascend announced it will not proceed with the non-binding term sheet to acquire MedMen NY, Inc.","Termination reason: MedMen cannot represent that its assets have not materially changed since December 31, 2021.","The non-binding term sheet was previously disclosed in Ascend's May 11, 2022 Form 8-K.","No financial terms, break-up fees, or regulatory conditions were specified in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356575,"accession_number":"0001628280-22-022901","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-08-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Q2 net revenue $97.5M (+14.6% QoQ), Adj. EBITDA margin 21.4%, FY2022 guidance reiterated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $97.5M, up 14.6% QoQ and 17.0% YoY; gross revenue $117.7M.","Net loss improved to $21.2M from $27.8M in Q1; Adj. EBITDA $20.9M (21.4% margin).","Cash and cash equivalents $140.6M; net debt $152.7M as of June 30, 2022.","Started adult-use sales at Rochelle Park, NJ; added 4,000 sq ft canopy in NJ.","FY2022 guidance: revenue $400-420M, Adj. EBITDA $75-85M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":182589000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356574,"accession_number":"0001628280-22-018501","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-07-05T23:59:59+00:00","items":["2.03","3.02","9.01"],"status":"ready","headline":"Ascend Wellness closes $28.5M incremental term loan, total debt $275M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Debt bears 9.5% fixed interest, matures August 27, 2025; no scheduled amortization.","Issued ~3.1M warrants exercisable at $3.10/share; up to 645k more at lender option.","Proceeds for working capital, acquisitions, capex, and other corporate purposes.","Financial covenants: liquidity ≥$20M, EBITDA/interest coverage ≥2.50x from Q2 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375010,"accession_number":"0001628280-22-015285","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-05-24T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"Ascend Wellness closes $36.5M incremental term loan, total debt facility now $246.5M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Incremental Commitment of $36.5M added to existing $210M term loan under Credit Agreement dated August 27, 2021.","Debt Facility bears fixed interest at 9.5% per annum, matures August 27, 2025, no scheduled principal amortization.","Proceeds used for working capital, growth investments, acquisitions, capital expenditures, and strategic initiatives.","Financial covenants require minimum Liquidity of $20M and minimum EBITDA-to-cash interest coverage ratios up to 2.50:1.00.","Prepayment premiums apply until February 27, 2025; amounts borrowed may not be re-borrowed once repaid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375009,"accession_number":"0001628280-22-013871","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-05-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ascend Wellness settles MedMen dispute; to pay $74M total, $15M extra consideration","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Signs term sheet to settle legal dispute with MedMen in NY Supreme Court.","Agrees to pay $15M additional consideration; total closing payment $74M, $4M deposit already paid.","Upon first recreational cannabis sale at MedMen NY dispensary, $14M earn-out payable.","MedMen to withdraw counterclaims; must pay $35M break fee if not closed within 30 days.","Ascend receives 99.99% controlling interest of MedMen NY; no additional earn-outs or debt assumption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375008,"accession_number":"0001628280-22-013854","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-05-11T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Ascend Wellness stockholders approve 2021 stock incentive and employee stock purchase plans","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved 2021 Stock Incentive Plan with 117.9M for, 291.9K against, 65.2K abstain.","Stockholders approved 2021 Employee Stock Purchase Plan with 118.1M for, 104.6K against, 26.7K abstain.","Five directors elected: Abner Kurtin, Joseph Hinrichs, Emily Paxhia, Francis Perullo, Scott Swid.","Ratification of Macias Gini & O'Connell LLP as auditor for 2022 passed with 128.0M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375007,"accession_number":"0001628280-22-013838","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q1 net rev $85.1M, net loss $27.8M, adj EBITDA $16.4M; PA expansion","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $85.1M, down 3.8% QoQ but up 28.7% YoY; net loss $27.8M vs $16.5M in Q4 2021.","Adjusted EBITDA $16.4M (19.2% margin); cash $143.8M, net debt $89.9M at quarter-end.","Launched value brand Simply Herb; 20 dispensaries and 213k sq ft canopy across 5 states.","Post-Q1: completed equity roll-up in Pennsylvania; plans cultivation facility and 6 dispensaries for 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":85090000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375006,"accession_number":"0001628280-22-010127","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-04-25T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Ascend Wellness completes acquisition of Story of PA CR for $53M (10.2M cash + 12.9M shares)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration ~$53M: $10.2M cash plus 12.9M AWH Class A common shares.","Merger closed April 19, 2022; Story becomes wholly-owned subsidiary of AWH Pennsylvania.","12.9M AWH shares issued as unregistered securities under Rule 506(b).","Escrow arrangement: shares released upon Pennsylvania DOH approval or triggering events within 5 years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":393413,"accession_number":"0001628280-22-005386","cik":1756390,"company_name":"Ascend Wellness Holdings, Inc.","ticker":"AAWH","form_type":"8-K","filed_at":"2022-03-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ascend Wellness Q4 net revenue down 6.2% QoQ to $88.5M; full year revenue up 131% to $332.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2021 net loss of $16.5M vs. $13.0M in Q3 2021; full year loss of $122.7M includes $32M non-cash IPO interest expense.","Adjusted EBITDA Q4 $19.8M (22.3% margin), down 16% QoQ; full year Adjusted EBITDA $79.4M, up 157.6% YoY.","Cash and equivalents $155.5M as of Dec 31, 2021; net debt $103.3M after $210M senior debt financing.","CEO cites Q4 competitive conditions and a 'pause' as new assets come online; eyes New Jersey adult-use market.","Grew dispensary count to 20, doubled cultivation capacity, and entered Ohio market during 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109605420.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-03-08T23:59:59+00:00|393413"}